Second-line Therapy
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer (NCT07320586) | Shandong Tumor Hospital | 2021-03-01 |
| Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC) (NCT04713059) | The Affiliated Hospital of Qingdao University | 2020-01-01 |
Track Second-line Therapy automatically
Every clearance here is in the API, with alerts when new ones post.